U.S. stock index futures jumped on Tuesday after a bruising selloff that has wiped out trillions of dollars since last week, as investors keenly await any sign of the U.S. opening up for negotiations over some of the aggressive tariffs.
At 9:18 a.m. ET, Dow e-minis were up 1294 points, or 3.39%, S&P 500 e-minis were up 167.25 points, or 3.28%, and Nasdaq 100 e-minis were up 569.25 points, or 3.24%.
Apple - Apple was up 3.1% in premarket trading after closing down 3.7% on Monday. It has fallen 19% over the past three trading sessions, its worst three-day stretch since July 20, 2001, when it fell more than 20%. The Wall Street Journal reported Monday thatApple plans to send more iPhones to the U.S. from Indiato offset the high cost of China tariffs. On Monday, President Donald Trump said he would impose an additional 50% tariff on China if Beijing doesn’t retract the 34% increase it threatened against the U.S. on Friday. China said Tuesday it would retaliate further if Trump carried out his threat. Most of Apple’s products are assembled in China.
Nvidia - Nvidia finished Monday as the best stock in the Dow Jones Industrial Average, rising 4.5%, while Apple closed as the worst. Nvidia, the maker of artificial-intelligence chips,was up 2.7% in premarket trading at $100.39. Semiconductors have been excluded so far from Trump’s tariff plans but the main risk to Nvidia is whether it gets caught up in escalating tensions between the U.S. and China.
Tesla - Shares of electric-vehicle maker Tesla were rising 2.8% after closing off 2.6% on Monday. Longtime Tesla bull, Dan Ives at Wedbush, lowered his price target on the stock to $315 a share, down from a Wall Street high of $550. Ives kept his Buy rating on the stock but said CEO Elon Musk has created a crisis with the Tesla brand. The stock has fallen almost 18% over the three trading sessions following Trump’s “Liberation Day” when the president announcedhigher-than-expected tariffs.
Broadcom - Broadcom rose 6.9% after the semiconductor and software company said its board authorized a new, $10 billion stock buyback program through the end of the year. The repurchase program “reflects the board’s confidence in the strength of Broadcom’s diversified semiconductor and infrastructure software product franchises,” said Hock Tan, president and CEO, in a statement.
CVS Health, UnitedHealth, Humana - Shares of CVS Health, UnitedHealth, and Humana—insurers that offer Medicare Advantage plans to seniors—were rising after the federal government announced an estimated$25 billion increase in payments to the plans in 2026. The increase in payments from the government was higher than initially expected and accounts for higher projected costs in the program, the Centers for Medicare and Medicaid Services said Monday. CVS rose 10.8%, UnitedHealth was up 9.2%, and Humana jumped 19%.
Super Micro Computer - Super Micro Computer was up 6.9% in premarket trading after closing up 11% Monday and finishing as thebest-performing stockin the S&P 500. Shares of the maker of artificial-intelligence servers now have risen 8.3% for the year but remain down 64% over the past 12 months.
Strategy - Strategy rose 4.1% in premarket trading. Shares of the largest corporate holder of Bitcoin, which does business as Strategy, said in a regulatory filing Monday that its unrealized loss on digital assets for the first quarter was $5.91 billion, which it expects will result in a net loss in the period despite an income tax benefit of $1.69 billion. The stock fell 8.7% on Monday.
Marvell Technology - Marvell Technology rose 7.5% after the semiconductor company said it would beselling its automotive ethernet businesstoInfineon Technologies in an all-cash transaction valued at $2.5 billion. The business is expected to generate revenue of between $225 million and $250 million in fiscal 2026, Marvell said. The divestiture is expected to close within the year.
Levi Strauss & Co - Levi Strauss rose 14.8% after the jeans maker reported first-quarter earnings that beat analysts’ estimates and said it was sticking with its outlook for 2025, excluding the impact from tariffs. The company said it anticipates tariffs would have “minimal impact” to its second-quarter margin outlook. Levi Strauss maintained that it expects a drop in full-year revenue of 1% to 2%.
Walgreens Boots Alliance - Walgreens, which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly profit as the pharmacy chain operator benefited from a turnaround effort that included closing underperforming stores. The shares gained 1.2% in premarket trading.
China pledged to retaliate against Donald Trump’s latest tariff threat and stepped up efforts to support the market, raising the risk of a prolonged trade war between the world’s two largest economies.
“The US threat to escalate tariffs on China is a mistake on top of a mistake,” the Chinese Ministry of Commerce said in a Tuesday statement. “If the US insists on its own way, China will fight to the end.”
The Chinese response came hours after Trump vowed to slap additional 50% import taxes on China unless it withdraws its tit-for-tat retaliation against his earlier levies. The blunt reaction suggests Beijing intends to resist the US president’s pressure campaign, dimming the prospect of a deal in the short term.
The European Commission proposed counter-tariffs of 25% on a range of U.S. goods on Monday in response to President Donald Trump's tariffs on steel and aluminium, a document seen by Reuters showed.
The tariffs on some goods will take effect May 16 and others later in the year, on December 1, the document said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.